News
Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc. is using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback